Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19

Despite its severe adverse effects, such as agranulocytosis, clozapine is the primary treatment for treatment-resistant schizophrenia. The established clozapine monitoring system has contributed to reducing agranulocytosis incidence and mortality rates. However, the pandemic coronavirus disease 2019...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramli, Fitri Fareez, Ali, Adli, Syed Hashim, Syed Alhafiz, Kamisah, Yusof, Ibrahim, Normala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582734/
https://www.ncbi.nlm.nih.gov/pubmed/34769806
http://dx.doi.org/10.3390/ijerph182111289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582734/
https://www.ncbi.nlm.nih.gov/pubmed/34769806
http://dx.doi.org/10.3390/ijerph182111289

Ejemplares similares